Abstract
Whether cerebrospinal fluid (CSF) neurone-specific enolase (NSE) contributes to the diagnosis of mitochondrial encephalomyopathies (MEMs) is unknown. Aim of the present study was thus to assess the validity of CSF-NSE in the diagnosis of MEM. CSF-NSE was determined in 24 controls, aged 28–88 years; and 23 MEM patients, aged 47–81 years. In controls, CSF-NSE was independent of sex (p = 0.849) and age (p = 0.346). Twenty-one MEM patients had clinical CNS involvement and two CNS abnormalities on imaging investigations exclusively. CSF cells were increased in 7, CSF protein in 17, CSF glucose in 1, and CSF lactate in 2 MEM patients. The upper reference limit of CSF-NSE was 14.66 ng/mL. CSF-NSE was elevated in 6 (26%) MEM patients. CSF-NSE was increased in a single MEM patient with subclinical CNS involvement. This study shows that CSF-NSE is elevated in only one quarter of the MEM patients. Determination of CSF-NSE appears to be of minor importance for the assessment of clinical or subclinical CNS involvement in MEM.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aksamit, A.J., Jr., Preissner, C.M., and Homburger, H.A. (2001). Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease. Neurology 57:728–730.
Beaudry, P., Cohen, P., Brandel, J.P., Delasnerie-Laupretre, N., Richard, S., Launay, J.M., and Laplanche, J.L. (1999). 14-3-3 Protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Dement. Geriatr. Cogn. Disord. 10:40–46.
Beems, T., Simons, K.S., Van Geel, W.J., De Reus, H.P., Vos, P.E., and Verbeek, M.M. (2003). Serum- and CSF-concentrations of brain specific proteins in hydrocephalus. Acta Neurochir. (Wien) 145:37–43.
Brockmann, K., Bjornstad, A., Dechent, P., Korenke, C.G., Smeitink, J., Trijbels, J.M., Athanassopoulos, S., Villagran, R., Skjeldal, O.H., Wilichowski, E., Frahm, J., and Hanefeld, F. (2002). Succinate in dystrophic white matter: A proton magnetic resonance spectroscopy finding characteristic for complex II deficiency. Ann. Neurol. 52:38–46.
Finsterer, J. (2004). Mitochondriopathies. Eur. J. Neurol. 11:163–186.
Finsterer, J. (2001). Cerebrospinal-fluid lactate in adult mitochondriopathy with and without encephalopathy. Acta Med. Aust. 28:152–55.
Finsterer, J. (2001). Visually evoked potentials in respiratory chain disorders. Acta Neurol. Scand. 104:31–35.
Leonard, J.V., and Schapira, A.H.V. (2000). Mitochondrial respiratory chain disorders I: Mitochondrial DNA defects. Lancet 355:299–304.
Martinez-Fernandez, E., Gil-Peralta, A., Garcia-Lozano, R., Chinchon, I., Aguilera, I., Fernandez-Lopez, O., Arenas, J., Campos, Y., and Bautista, J. (2001). Mitochondrial disease and stroke. Stroke 32:2507–2510.
Musumeci, O., Naini, A., Slonim, A.E., Skavin, N., Hadjigeorgiou, G.L., Krawiecki, N., Weissman, B.M., Tsao, C.Y., Mendell, J.R., Shanske, S., De Vivo, D.C., Hirano, M., and DiMauro, S. (2001). Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 56:849–855.
Ohkoshi, N., Ishii, A., Shiraiwa, N., Shoji, S., and Yoshizawa, K. (1998). Dysfunction of the hypothalamic-pituitary system in mitochondrial encephalomyopathies. J. Med. 29:13–29.
Ohno, K., Isotani, E., and Hirakawa, K. (1997). MELAS presenting as migraine complicated by stroke: Case report. Neuroradiology 39:781–784.
Osterlundh, G., Bjure, J., Lannering, B., Kjellmer, I., Uvebrant, P., and Marky, I. (1999). Regional cerebral blood flow and neuron-specific enolase in cerebrospinal fluid in children with acute lymphoblastic leukemia during induction treatment. J. Pediatr. Hematol. Oncol. 21:378–383.
Pleines, U.E., Morganti-Kossmann, M.C., Rancan, M., Joller, H., Trentz, O., and Kossmann, T. (2001). S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J. Neurotrauma 18:491–498.
Steinhoff, B.J., Tumani, H., Otto, M., Mursch, K., Wiltfang, J., Herrendorf, G., Bittermann, H.J., Felgenhauer, K., Paulus, W., and Markakis, E. (1999). Cisternal S100 protein and neuron-specific enolase are elevated and site-specific markers in intractable temporal lobe epilepsy. Epilepsy Res. 36:75–82.
Studahl, M., Rosengren, L., Gunther, G., and Hagberg, L. (2000). Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction. J. Neurol. 247:636–642.
Thornberg, E., Thiringer, K., Hagberg, H., and Kjellmer, I. (1995). Neuron specific enolase in asphyxiated newborns: Association with encephalopathy and cerebral function monitor trace. Arch. Dis. Child. Fetal Neonatal. Ed. 72:F39–F42.
Weinstock, A., Giglio, P., Cohen, M.E., Bakshi, R., Januario, J., and Balos, L. (2002). Diffuse magnetic resonance imaging white-matter changes in a 15-year-old boy with mitochondrial encephalomyopathy. J. Child. Neurol. 17:47–49.
Younes-Mhenni, S., Thobois, S., Streichenberger, N., Giraud, P., Mousson-de-Camaret, B., Montelescaut, M.E., Broussolle, E., and Chazot, G. (2002). Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (Melas) associated with a Fahr disease and cerebellar calcifications. Rev. Med. Int. 23:1027–1029.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Finsterer, J., Exner, M. & Rumpold, H. Cerebrospinal Fluid Neurone-Specific Enolase in Mitochondrial Encephalomyopathies. Metab Brain Dis 20, 81–86 (2005). https://doi.org/10.1007/s11011-005-2479-9
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11011-005-2479-9